Genetic Studies Suggest A Novel Portuguese Origin For Hemoglobin Porto Alegre by Faustina P. et al.
haematologica 2004; 89(8):August 2004
Letters to the Editor
1009
Red Cell Disorders
Genetic studies suggest a novel Portuguese origin for
hemoglobin Porto Alegre
Molecular studies performed in Portuguese and Brazil-
ian cases of hemoglobin Porto Alegre [β9 Ser→Cys]
revealed that the mutation is in association with the
Mediterranean haplotype I and framework 1 and that it
is also in cis with an undescribed intragenic polymor-
phism (codon 27, GCC→GCT). Based upon these findings,
and reinforced by historical data, we suggest that hemo-
globin Porto Alegre originated from a single mutational
event in the Portuguese population and was then spread
to South America, namely to Brazil.haematologica 2004; 89:1009-1010
(http://www.haematologica.org/2004/8/1009)
Hemoglobin (Hb) Porto Alegre [β9 (A6) Ser→Cys] was
discovered in 1963 in a Caucasian Brazilian family1 and was
subsequently observed in members of several other families
in Brazil,2,3 Cuba4 and the Canary Islands.5 Malcorra-Azpiazu
and colleagues suggested in 1993 that the Hb Porto Alegre
mutation originated in the population of the Canary Islands
and was then exported to the Portuguese and Spanish
colonies of South America.5 In this report, we describe four
novel cases of Hb Porto Alegre, found in two unrelated Por-
tuguese families, and we propose a novel mutational event
for this variant. 
Portuguese carriers of Hb Porto Alegre, as others, pre-
sented no clinical or hematologic features. Their red blood
cell indices were obtained with an automated cell counter.
Hb analysis was performed by cellulose acetate elec-
trophoresis at pH 8.4, isoelectric focusing, and low pressure
liquid chromatography (Hb-Gold, Drew Scientific Ltd., Bar-
row-in-Furness, Cumbria, England). Globin chains were sep-
arated by reversed phase-high performance liquid chro-
matography6 (Gold Beckman Liquid Chromatograph, Beck-
man Instruments Inc, Fullerton, CA, USA). All these bio-
chemical techniques revealed the presence of one abnormal
Hb variant (Figure 1). Total genomic DNA of the Hb variant
carriers was isolated from peripheral blood leukocytes by a
salting-out procedure.7 The coding regions of the HBB gene
were amplified by polymerase chain reaction (PCR). Direct
sequencing of PCR products was performed using an ABI
PRISM 3100 DNA Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA). 
The HBB sequence analysis revealed a base substitution
at codon 9 (TCT→TGT), and consequently, the variant was
identified as Hb Porto Alegre. Unexpectedly, another
sequence alteration was detected in codon 27 (GCC→GCT)
of the same gene (Figure 2); this alteration does not lead to
an amino acid substitution (both coding for alanine). β-glo-
bin cluster haplotype, which segregates with the variant,
was assigned after examining nine restriction endonuclease
sites: HincII (ε), XmnI (5’to Gγ), HindIII (within Gγ and Aγ),
HincII (within and 3’ to ψβ), HinfI (5’to β), AvaII (within β),
and HinfI (3’to β). The amplified products were digested
with the appropriate restriction enzymes under the condi-
Figure 1. Reversed phase - high performance liquid chro-
matograph globin chain profile found in a carrier of Hb
Porto Alegre. In this case, integration of the peak areas
revealed 39.5% of βHb Porto Alegre and 58.0% of βA-chain.
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Figure 2. HBB sequence analysis showing the codon 9 (TCT→TGT) mutation causing Hb Porto Alegre and the linked
codon 27 polymorphism (GCC→GCT).
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tions recommended by the manufacturer. Family studies
allowed the unequivocal association of Hb Porto Alegre with
Mediterranean haplotype I8, and with framework 18 and also
revealed its segregation, in cis, with the codon 27 novel
intragenic polymorphism.
Because of historical data, we hypothesized whether Hb
Porto Alegre described in Brazil could have a Portuguese ori-
gin, and in order to answer this question, the same molecular
approach was performed in the Brazilian family described by
Gonçalves et al.3 As we expected, the Brazilian case present-
ed the same, above described, genetic background. 
As suggested by Malcorra-Azpiazu and colleagues in 1993,5
the several cases of Hb Porto Alegre described in the Canary
Islands could be indicative that the mutational event giving
rise to this variant had occurred there. Subsequently, the
mutation could have spread to Spanish colonies in South
America. This hypothesis is, in fact, compatible with histori-
cal data. The indigenous inhabitants of the Canary Islands —
the Guanches — were occasionally visited by a variety of
groups: Romans (40 B.C.), then the Arabs (999), and then in
the 13th and 14th centuries many European conquerors, includ-
ing the Portuguese. In the 15th century the Islands was con-
tended between the Portuguese and Spaniards until 1479,
when the Treaty of Alcácovas declared Spanish sovereignty
over the islands. These islands became an important base for
voyages to the Americas.9 However, knowing that Hb Porto
Alegre has been found in the Portuguese population, another
hypothesis could be forwarded. It is possible that Portuguese
carriers of Hb Porto Alegre left progeny on Canary Islands and
that the mutation subsequently expanded to the South Amer-
ica in the 15th and following centuries. Furthermore, it is
known that after the discovery of Brazil by the Portuguese in
1500, a massive transmigration of the Portuguese population
to Brazil occurred until the mid 20th century.10 In conclusion,
based on our molecular findings, and considering the above
historical data, we propose that Hb Porto Alegre had one orig-
inal mutational event in the Portuguese population and that
it was spread to South America, namely to Brazil. 
This hypothesis could find support from studies of the
genetic background of the Spanish and Cuban Hb Porto Ale-
gre cases and efforts were made to contact the laboratories
where these cases had been characterized. We have obtained
information that in Cuba another case of the variant was
detected, curiously in a family of Portuguese origin with the
surname Ferreira (G. Martinez, personnel communication).
Unfortunately, none of the above mentioned cases of Hb Por-
to Alegre was accessible for molecular studies.
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Red Cell Disorders
Simultaneous detection of α-thalassemia andβ-thalassemia by oligonucleotide microarray 
In this study, we describe a reliable microarray-based
assay for the simultaneous detection of α/β-globin geno-
types. The efficiency and specificity of this method were
evaluated by blinded analysis of 1,880 samples. The assay
provides unambiguous detection of complex combinations
of heterozygous, compound heterozygous and homozygous
α/β-thalassemia genotypes.haematologica 2004; 89:1010-1012
(http://www.haematologica.org/2004/8/1010)
Thalassemia is most common genetic disorder in Asia. The
approach to dealing with the problem of thalassemia is to
prevent and control the birth of new cases. This requires an
accurate identification of couples at high risk of tha-
lassemia. A previous study has shown that microarrays can
be used to detect thalassemia.1 In this study, we have devel-
oped a microarray-based assay for rapid detection of the
common severe thalassemia defects found in Asia. This
screening test can accurately give a specific diagnosis of the
thalassemia genotype. To identify mutations of α/β-tha-
lassemia, a total 38 of oligonucleotide probes are immobi-
lized on slides and a single hybridization is performed with
fluorescence-labeled multiplex polymerase chain reaction
(PCR) products. Hybridization is detected by fluorescence
scanning, and the α/β-globin genotypes are assigned by
quantitative analysis of the hybridization results.
A pair of probes was designed for each point mutation,
one complementary to the normal sequence and the other
to the variant. The probes are 15~20mer oligonucleotides
with the mismatch base placed in the center of the
                                                   
